10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Dengue fever, caused by the dengue virus transmitted primarily by Aedes mosquitoes, is a significant global health concern. The infection is prevalent in tropical and subtropical regions, placing over half the world's population at risk. Dengue manifests in a spectrum of clinical presentations, ranging from asymptomatic cases to severe forms, including dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Common symptoms include sudden high fever, severe headaches, joint and muscle pain, skin rash, and mild bleeding tendencies. Severe forms of dengue can lead to plasma leakage, organ impairment, and, in extreme cases, death. The rapid urbanization and increased travel contribute to the virus's global spread. Diagnosis relies on clinical evaluation, supported by laboratory tests such as polymerase chain reaction (PCR) and serological assays. Management involves supportive care, as no specific antiviral treatment is available. Vector control measures and public health campaigns are crucial for preventing dengue transmission.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria